IL-3R alpha/CD123 Antibody [Janelia Fluor® 646]
Novus Biologicals, part of Bio-Techne | Catalog # AF841J

Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Janelia Fluor 646
Antibody Source
Polyclonal Goat IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
S. frugiperda insect ovarian cell line Sf 21-derived recombinant human IL‑3 R alpha/CD123
Specificity
Detects human IL‑3 R alpha/CD123 in direct ELISAs and Western blots. In direct ELISAs and Western blots, approximately 2% cross‑reactivity with recombinant human (rh) IL-2 sR beta, rhIL-2 sR gamma, and rhIL-6 sR is observed.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Applications for IL-3R alpha/CD123 Antibody [Janelia Fluor® 646]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: IL-3R alpha
Long Name
Interleukin 3 Receptor alpha
Alternate Names
CD123, IL-3 R alpha, IL-3Ra, IL3R alpha, IL3RA
Gene Symbol
IL3RA
Additional IL-3R alpha Products
Product Documents for IL-3R alpha/CD123 Antibody [Janelia Fluor® 646]
Product Specific Notices for IL-3R alpha/CD123 Antibody [Janelia Fluor® 646]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...